Sector: Healthcare | Industry: Pharmaceuticals |
Company Contact | |
Address: | 700 TECH COURT LOUISVILLE CO 80027 |
Tel: | 1-416-5943849 |
Website: | https://www.charlottesweb.com |
IR: | See website |
Key People | ||
William Morachnick Chief Executive Officer, Director | Jessica Saxton Chief Financial Officer | Jared Stanley Chief Operating Officer |
Stephen Rogers Senior Vice President, General Counsel, Corporate Secretary | Sarah Cambridge Chief Accounting Officer | Andrew Shafer Chief Marketing Officer |
Business Overview |
Charlotte's Web Holdings, Inc. (Charlotte's) is engaged in providing hemp extract wellness products under a family of brands which includes Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp. Charlotte's Web branded products start with its hemp genetics that are 100% North American farm grown and manufactured into hemp extracts containing naturally occurring phytocannabinoids, including cannabidiol (CBD), cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids and other beneficial hemp compounds. Charlotte's Web product categories include full spectrum hemp extract oil tinctures (liquid products), gummies (sleep, calm, immunity, exercise recovery, daily wellness, THC-free), capsules, topical creams and lotions, as well as products for pets. Charlotte's Web products are distributed to retail outlets and health care practitioners, as well as online through the Company's Website at www.Charlottesweb.com. |
Financial Overview |
For the six months ended 30 June 2023, Charlotte's Web Holdings Inc revenues decreased 14% to $33M. Net loss decreased 100% to $68K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Change in fair value of financial instru increase from $100K to $9.6M (income). |
Employees: | 170 as of Dec 31, 2022 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $37.56M as of Jun 30, 2023 |
Annual revenue (TTM): | $93.15M as of Jun 30, 2023 |
EBITDA (TTM): | -$53.49M as of Jun 30, 2023 |
Net annual income (TTM): | -$57.96M as of Jun 30, 2023 |
Free cash flow (TTM): | -$8.07M as of Jun 30, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 152,825,118 as of Jun 30, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |